Improving Response Durability in Later-Line Metastatic Colorectal Cancer: Clinical Insights and Real-World Evidence

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Essentials: Optimal Protocols to Build Strength & Grow Muscles | Dr. Andy Galpin 37 min · 24 Sep 2026 · Huberman Lab

Why do we itch? 7 min · 24 Sep 2026 · 6 Minute English

307. Dr. Josh Axe, Dr. Will Cole & Taylor Dukes: Toxoplasma Gondii Is Linked to Brain Tumors 33 min · 24 Sep 2026 · The Ultimate Human with Gary Brecka

A Grand Canyon Mishap, "Rain" in Ireland, & an Airport Disaster: Listener Episode #28 45 min · 24 Sep 2026 · Family Trips with the Meyers Brothers

PM 24 Sep 26: ASX reacts to higher unemployment 9 min · 24 Sep 2026 · CommSec Market Update

FREE SUBS TASTER: Is It Just Us, Or Does Everyone Sound Exactly The Same? 4 min · 24 Sep 2026 · Mamamia Out Loud

Report any issue

Source

Recorded30 Jul 2026

Publisherc.answersincme.com ↗

Handlerec:19583591

Show notes

Please visit answersincme.com/860/103518989-replay3 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by John Strickler, MD and Chiara Cremolini, MD, PhD. In this activity, experts in metastatic colorectal cancer (mCRC) discuss real-world evidence and clinical insights related to durable responses and long-term benefits in later-line care. Upon completion of this activity, participants should be better able to: Propose treatment plans based on predictors of durable benefit and real-world evidence.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in